Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

NCT01114217 is registered in ClinicalTrials.gov with AMAG Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01114217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01114217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
Lead sponsor
AMAG Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 27, 2010
Completion date
April 23, 2013
Enrollment
634 (actual)
Sites
140

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia